Choose the brand aligned with your industry so we can best serve your needs.
The Quickvue™ At-Home OTC COVID-19 test can accurately detect the Omicron variant (among others) of the Sars-CoV-2, the potentially deadly virus that can lead to COVID-19.
Includes | Individually wrapped sterile foam swabs, test strips, single-use strips, pre-filled tubes, tube holder, instruction sheet |
---|---|
Type | At-home COVID Test Kit |
Format | Kit |
Sample Type | Nasal Swab |
Detectable Analytes | SARS-CoV-2 |
Clia Complexity | Waived (FDA, EUA) |
Test Time | 10 mins. |
Easy to use 15 min. rapid antigen test for detecting active infections of COVID-19
The CLINITEST Rapid COVID-19 Antigen Self-Test is intended to aid in the rapid detection of SARS-CoV-2 (the virus that causes COVID-19) and provides accurate results in just 15 minutes.
The cobas SARS-CoV-2 & Influenza A/B nucleic acid test is a multiplex real-time polymerase chain reaction (PCR) test that detects and differentiates SARS-CoV-2, Influenza A, and Influenza B. This control kit is for running a control test/lot validation for the assay.
Detects SARS-CoV-2 antigens directly from anterior nares swab specimens. The QuickVue SARS Antigen Test provides accurate and reliable results in 10 minutes.
The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
Microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens
Uses immunofluorescence-based lateral flow technology in a sandwich design for qualitative detection of nucleocapsid protein from SARS-CoV-2. Provides automated and objective results in 15 minutes, allowing for testing of patients suspected of COVID-19/2019-nCoV in near-patient testing environments.
Includes | Cassettes, Reagent tubes, Reagent solution, Swabs, Pipettes (sufficient for 25 tests); Control swabs 1-pos 1-neg |
---|---|
Description | Test Kit |
For Use With (Equipment) | For use with Quidel Sofia 2 Analyzer, Cat. No. 20299. |
Quantity | 25 Tests/Pk. or 300 Tests/Cs. |
Clia Complexity | Waived |
Test Time | 15 min. |
Nucleic acid test for use on cobas Liat system is the first real-time RT-PCR test authorized for use in screening and testing asymptomatic/symptomatic individuals for SARS-CoV-2 at the point of care
Starter Kit including for use with Sofia 2 Flu + SARS Test Kit
This Respiratory Viral Panel is able to detect and differentiate SARS-CoV2, influenza A, influenza B, and RSV.
For in vitro qualitative detection of human coronavirus SARS-CoV-2 from viral RNA extracted from nasal, nasopharyngeal (NP) or oropharyngeal (OP) swab specimens from patients with signs and symptoms of COVID-19, Assay targets non-structural Polyprotein (pp1ab) of SARS-CoV-2 virus
Type | COVID Testing Kit |
---|---|
For Use With (Equipment) | Emergency Use Authorization (EUA) for use on Applied Biosystems™ 7500 Fast Dx, Applied Biosystems 7500 Standard, Roche LightCycler™ 480 Instrument II, Roche cobas™ z 480, Qiagen Rotor-Gene™ Q, Bio-Rad CFX96 Touch™, Thermo Fisher QuantStudio™ 7 Pro |
Positive and negative quality controls to complete QC assessment of LumiraDx instrument and LumiraDx SARS-CoV-2 Ag test strips
For in vitro qualitative detection of human coronavirus SARS-CoV-2 from viral RNA extracted from nasal, nasopharyngeal (NP) or oropharyngeal (OP) swab specimens from patients with signs and symptoms of COVID-19, Assay targets non-structural Polyprotein (pp1ab) of SARS-CoV-2 virus
Content And Storage | 2°C to 8°C |
---|---|
DoA Calibrators | No |
Packaging Type | Kit |
Detectable Analytes | SARS-CoV-2 |
Quantity | 96 Tests/Kit |
CE Marker | Yes |
For Use With (Application) | RT-PCR |
Clia Complexity | High |
Test Time | <75 min. after extraction |
Includes | Tests and controls |
Specificity | NPA – 92/92 = 100% (95% CI: 95.99 to 100%) |
Type | Molecular Testing |
Sensitivity | PPA – 92/92 = 100% (95% CI: 95.99 to 100%) |
Control Sets | Included |
For Use With (Equipment) | Emergency Use Authorization (EUA) for use on bioMerieux NucliSENS™ easyMAG™ system or EMAG system, followed by RT-PCR on one of six thermocyclers: Applied Biosystems™ 7500 Fast Dx, Applied Biosystems 7500 Standard, QuantStudioTM Real-Time PCR Instrument, Roche LightCycler™ 480, BioRad CFX96 Touch, or Qiagen Rotor-Gene Q |
Shelf Life | 6 Months from DOM |
Certifications/Compliance | Emergency Use Authorization (EUA) |
The SCoV-2 Ag Detect Rapid Test Kit can be used for testing symptomatic or asymptomatic patients using a direct nasal sample that gives results in about 20 minutes.
Disposable | Yes |
---|---|
Content And Storage | 15°C to 30°C |
Form | Liquid |
Detectable Analytes | SARS-CoV-2 Antigens |
CE Marker | Yes |
For Use With (Application) | Intended for the qualitative detection of SARS-CoV-2 Nucleoprotein antigen in direct anterior nasal swab specimens from individuals who are suspected of COVID-19 by their healthcare provider within 5 days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. |
Clia Complexity | Waived |
Test Time | 20 Min. |
Includes | Pouched cassettes, 1 positive control, 1 negative control, sterile swabs, lysis buffer |
Specificity | 1 |
Type | SARS-CoV-2 Rapid Antigen Test |
Sensitivity | 0.8667 |
Sample Type | Direct Nasal Swab |
Shelf Life | 6 Months |
Species | Human |